SHINE to meet with NRC staff
SHINE, which plans to build a medical isotope production plant in Janesville, requested the meeting to provide NRC staff with an update on the project and discuss licensing procedures.
For those members of the public who can't make it to Rockville, Md., for Thursday's meeting, the NRC has set up a call-in telephone line to listen in on the meeting or ask questions.
The agenda for the three-hour meeting does include a specific item for public questions.
To ask questions, which will be allowed only of NRC staff, pre-registration is necessary, and it must be done by 4 p.m. today.
Proprietary information will be discussed at certain times during the meeting. Those portions will be closed to members of the public.
Participants from the NRC include members of the Office of Nuclear Reactor Regulation, the Office of Federal and State Materials and Environmental Management Programs, the Office of Nuclear Material Safety and Safeguards, the Office of Nuclear Regulatory Research and the Office of the General Counsel.
The Janesville City Council last week voted 4-1 to approve a development agreement with SHINE that provides $5 million in incentives and $4 million in a private-sector loan guarantee to private investors.
SHINE has agreed to create 125 jobs within five years of beginning production, which could happen by 2015 if the company passes muster with state and federal regulatory agencies.
Salaries are estimated at $60,000 a year.
Representatives of SHINE Medical Technologies will meet with representatives of the U.S. Nuclear Regulatory Commission from 8-11 a.m. Thursday.
While the meeting is in Maryland, members of the public can ask questions of NRC staff by phone.
For information on accessing the teleconference and to pre-register, contact Steve Lynch at (301) 415-1524 or email@example.com, or Marcus Voth at (301) 415-1210 or firstname.lastname@example.org.
Pre-registration must be done by 4 p.m. today.